
FDA Grants Approval to Edwards’ EVOQUE Valve Replacement System, Marking a Milestone as the First Transcatheter Therapy for Tricuspid Valve
Edwards Lifesciences Corporation (NYSE: EW) has announced the FDA approval of its EVOQUE tricuspid valve replacement system, marking a groundbreaking achievement as the first transcatheter therapy authorized for treating tricuspid…











